These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36175971)

  • 1. Assessment of IMPT versus VMAT plans using different uncertainty scenarios for prostate cancer.
    Butkus MP; Brovold N; Diwanji T; Xu Y; De Ornelas M; Dal Pra A; Abramowitz M; Pollack A; Dogan N
    Radiat Oncol; 2022 Sep; 17(1):162. PubMed ID: 36175971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of daily dose accumulation for robustly optimized intensity modulated proton therapy treatment of prostate cancer.
    Xu Y; Diwanji T; Brovold N; Butkus M; Padgett KR; Schmidt RM; King A; Dal Pra A; Abramowitz M; Pollack A; Dogan N
    Phys Med; 2021 Jan; 81():77-85. PubMed ID: 33445124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
    Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
    Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
    Rojo-Santiago J; Korevaar E; Perkó Z; Both S; Habraken SJM; Hoogeman MS
    Radiother Oncol; 2023 Sep; 186():109729. PubMed ID: 37301261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy - A proton versus photon comparison.
    De Ornelas M; Iorio GC; Bossart E; Ricardi U; Seldon C; Dal Pra A; Butkus M
    Phys Med; 2023 Aug; 112():102644. PubMed ID: 37487297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
    Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
    Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing photon and proton-based hypofractioned SBRT for prostate cancer accounting for robustness and realistic treatment deliverability.
    Goddard LC; Brodin NP; Bodner WR; Garg MK; Tomé WA
    Br J Radiol; 2018 May; 91(1085):20180010. PubMed ID: 29436852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy.
    Teoh S; George B; Fiorini F; Vallis KA; Van den Heuvel F
    Br J Radiol; 2020 Mar; 93(1107):20190584. PubMed ID: 31977241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
    Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
    Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT.
    Gutierrez A; Rompokos V; Li K; Gillies C; D'Souza D; Solda F; Fersht N; Chang YC; Royle G; Amos RA; Underwood T
    Acta Oncol; 2019 Dec; 58(12):1765-1774. PubMed ID: 31429359
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of robust optimization against geometric uncertainties in TomoHelical planning for prostate cancer.
    Yagihashi T; Inoue K; Nagata H; Yamanaka M; Yamano A; Suzuki S; Yamakabe W; Sato N; Omura M; Inoue T
    J Appl Clin Med Phys; 2023 Apr; 24(4):e13881. PubMed ID: 36576418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
    Franceschini D; Cozzi L; Fogliata A; Marini B; Di Cristina L; Dominici L; Spoto R; Franzese C; Navarria P; Comito T; Reggiori G; Tomatis S; Scorsetti M
    Radiat Oncol; 2022 Aug; 17(1):150. PubMed ID: 36028862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric Comparison of Helical Tomotherapy, Volumetric-Modulated Arc Therapy, and Intensity-Modulated Proton Therapy for Angiosarcoma of the Scalp.
    Mizuno T; Tomita N; Takaoka T; Tomida M; Fukuma H; Tsuchiya T; Shibamoto Y
    Technol Cancer Res Treat; 2021; 20():1533033820985866. PubMed ID: 33517860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer.
    Kato T; Ono T; Narita Y; Komori S; Murakami M
    Med Dosim; 2022 Autumn; 47(3):216-221. PubMed ID: 35346554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy.
    Oonsiri P; Nantavithya C; Lertbutsayanukul C; Sarsitthithum T; Vimolnoch M; Tawonwong T; Saksornchai K
    Radiat Oncol; 2022 Jan; 17(1):20. PubMed ID: 35093111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
    Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
    Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
    Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
    Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.